CDSCO panel asks Cipla to include more Govt sites in Budesonide, Formoterol FDC study Medical Dialogues Team25 Nov 2021 6:02 PM ISTNew Delhi: Recommending to include more government sites, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Sun Pharma Dapagliflozin, Glimepiride, Metformin FDC gets CDSCO panel nod for phase 3 trial Medical Dialogues Team24 Nov 2021 6:28 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
CDSCO panel allows Novartis to waiver conditions for study of anti malarial drug Cipargamin Medical Dialogues Team23 Nov 2021 5:59 PM ISTNew Delhi: Based on the justification provided by the pharma major Novartis, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Torrent pharma gets CDSCO nod to market additional strength of Amlodipine,Olmesartan Medoxomil FDC Medical Dialogues Team22 Nov 2021 5:34 PM ISTNew Delhi: Approving the waiver of the phase 3 clinical trial, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Novartis gets CDSCO panel nod to study Dabrafenib, Trametinib FDC Medical Dialogues Team21 Nov 2021 11:45 AM ISTNew Delhi: In a significant development, pharma major Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central...
Novartis gets CDSCO panel nod to conduct phase 3 study of anti-cancer drug Asciminib Medical Dialogues Team18 Nov 2021 4:25 PM ISTNew Delhi: In a significant development, major drug-maker Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the...
Cadila gets CDSCO panel nod to manufacture, market Calcium Polystyrene Sulphonate suspension Medical Dialogues Team16 Nov 2021 6:57 PM ISTNew Delhi: Pharmaceutical major Cadila Healthcare has got a green signal from the Subject Expert Committee (SEC) functional under the Central Drugs...
Alkem gets CDSCO panel okay to manufacture, market Metformin, Sitagliptin FDC Medical Dialogues Team12 Nov 2021 6:18 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Torrent Pharma gets CDSCO panel nod to manufacture, market Pregabalin, Duloxetine FDC Medical Dialogues Team7 Nov 2021 11:45 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Submit interim safety report: CDSCO panel tells Novartis for phase 3 study of intrathecal OAV-101 Medical Dialogues Team7 Nov 2021 9:30 AM ISTNew Delhi: In a significant development, drug firm Novartis has got a green signal from the Subject Expert Committee (SEC) functional under the...
Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication Medical Dialogues Team27 Oct 2021 1:21 PM ISTNew Delhi: In a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
CDSCO panel junks Novartis proposed clinical trial of oral treatment for C3 glomerulopathy Medical Dialogues Team25 Oct 2021 4:49 PM ISTNew Delhi: In a setback to pharma major Novartis, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization...
